This inventor holds 1 USPTO granted patent and 3 published patent applications and 2 EPO patents. Top assignee: Bayer Aktiengesellschaft. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Sven-Oliver Borchert: Innovator in Virus Inactivation Technology
Introduction
Sven-Oliver Borchert is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of virus inactivation technology. His innovative approach has led to the development of a unique device that enhances the safety and efficiency of process fluids.
Latest Patents
Sven-Oliver Borchert holds 1 patent for his invention titled "Unit operation and use thereof." This patent describes a unit operation formed by a device designed for continuous virus inactivation of a continuous flow of a process fluid. The device features a single inlet at one end and an outlet at the opposite end, along with at least one HFI, which is characterized by the inclusion of at least one installation.
Career Highlights
Sven-Oliver Borchert is currently employed at Bayer Aktiengesellschaft, a leading global company in the pharmaceutical and life sciences sector. His work at Bayer has allowed him to focus on innovative solutions that address critical health and safety challenges.
Collaborations
Sven-Oliver collaborates with talented coworkers, including Lisa Marie Waldschmidt and Laura David. Their combined expertise contributes to the advancement of their projects and the successful implementation of innovative technologies.
Conclusion
Sven-Oliver Borchert's contributions to virus inactivation technology exemplify the impact of innovation in the field of health and safety. His work continues to pave the way for advancements that benefit society.